(PRWEB) April 21, 2014
The Corporate Whistleblower Center says, "Aside from doing something in the best interest for innocent patients, we believe medical doctors who blow the whistle on drug makers, or medical device manufacturers providing kickback, or payoffs can be incredibly profitable for the doctor. The only caveat is, the doctor must have substantial proof that is well documented." For more information about federal whistleblower programs, physicians, or healthcare professionals can call the Corporate Whistleblower Center anytime at 866-714-6466.
According to a December 3013 DOJ press release, Abbott Laboratories has agreed to pay the United States Government $5.475 million to resolve allegations that it violated the False Claims Act by allegedly paying kickbacks to doctors who implanted the company’s carotid, biliary, and peripheral vascular products. Abbott Laboratories is a global pharmaceuticals and health care products company based in Abbott Park, Ill.
The settlement resolves allegations that Abbott allegedly paid prominent physicians for teaching assignments, speaking engagements, and attending conferences. The expectation was that allegedly these physicians would arrange for the hospitals with which they were affiliated with to purchase Abbott’s carotid, biliary, and peripheral vascular products. As a result, the United States Government alleged Abbott violated the Anti-Kickback Act, and submitted false claims to Medicare for procedures in which these Abbott products were used. http://CorporateWhistleblowerCenter.Com
In this case, the whistleblower will receive a total payment of more than $1 million.
Simple rules for a whistleblower from the Corporate Whistleblower Center:
Any type of insider or employee who possesses significant proof of their employer or a government contractor defrauding the federal government is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466 or via their web site at http://CorporateWhistleBlowerCenter.Com
For attribution purposes please refer to the December 2013 Justice Department press release on this matter: http://www.justice.gov/opa/pr/2013/December/13-civ-1367.html
Case number: United States ex rel. Peters et al. v. Abbott Laboratories, Inc., Civil Action No. 3:09-CV-430 (E.D. Tenn.)